---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-016455"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2026-05-12T20:46:03+00:00"
generated_at: "2026-05-12T20:47:30.341105+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.95
calibrated_materiality_score: 0.95
confidence: "high"
source: SEC EDGAR
---

# BIO-key receives Nasdaq delisting notice; stock to move to OTC Markets on May 13

## Summary
- Nasdaq suspends BKYI trading after close May 12 for failing to maintain $1 bid price for 10 consecutive days by May 4 and late Form 10-K.
- Company will request a hearing before a Nasdaq Hearings Panel to appeal delisting; no guarantee of reinstatement.
- Stock to be quoted on OTC Markets under symbol BKYI starting May 13; reverse stock split was effective April 30 but timing fell short.
- CEO states 1H'26 revenue expected to rise 50% to $5M vs $3.3M in 1H'25; targets profitability vs $1.9M net loss in 1H'25.
- Cash position expected to remain in line with year-end 2025 level; company retains listing consultants to expedite Nasdaq return.

## SEC filing metadata
- accession: 0001437749-26-016455
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2026-05-12T20:46:03+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.95
- calibrated_materiality_score: 0.95
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774926016455/0001437749-26-016455-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774926016455/bkyi20260512_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-016455
- JSON: https://secwatch.observer/filing/0001437749-26-016455.json
- Plain text: https://secwatch.observer/filing/0001437749-26-016455.txt

## Key facts
- Listing & Compliance Notices
  BIO KEY INTERNATIONAL INC received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: May 6, 2026, BIO-key International, Inc. (the “ Company ”) received notice from the staff of The Nasdaq Stock Market, LLC (“ Nasdaq ”) stating that the Company had not regained compliance with Nasdaq Listing Rule 5550(a)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1019034/000143774926016455/0001437749-26-016455-index.htm
- Listing & Compliance Notices
  BIO KEY INTERNATIONAL INC received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: late filing
  - Rules: 5250(c)(1)
  source text: May 6, 2026, BIO-key International, Inc. (the “ Company ”) received notice from the staff of The Nasdaq Stock Market, LLC (“ Nasdaq ”) stating that the Company had not regained compliance with Nasdaq Listing Rule 5550(a)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1019034/000143774926016455/0001437749-26-016455-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.